Description
| Product Name | Format | CAT.No | Size |
| Microalbumin Immunoturbidimetric without sample pre-dilution | LS | BXC0471A | R1: 1 x 50ml R2: 1 x 10ml R4: 5 x 1ml (C1-C5) |
Product Description
The Biorex Diagnostics Microalbumin Immunoturbidimetric Assay is a ready-to-use quantitative test for the measurement of microalbumin in urine, providing essential information for the early detection of renal impairment in patients with diabetes, hypertension, and other conditions associated with increased renal risk. Microalbumin is a sensitive biomarker for early kidney damage, particularly in diabetic nephropathy, where small increases in urinary albumin excretion can indicate the onset of renal dysfunction before more severe symptoms develop. Early and accurate detection enables timely clinical intervention, helping to prevent progression to chronic kidney disease and associated complications.
Key Features
- Quantitative determination of urinary microalbumin within the clinically relevant range
- Clinically relevant for early detection of diabetic nephropathy and hypertension-related renal damage
- Sensitive indicator for renal function assessment and cardiovascular risk evaluation
- Ready-to-use reagents streamline workflow, reduce preparation errors, and ensure consistent results
- Compatible with automated analysers, kinetic assays, and routine clinical laboratory protocols
Benefits
The Biorex Microalbumin Assay delivers precise, reliable, and reproducible measurement of urinary microalbumin, supporting early diagnosis, patient monitoring, and research applications. Its high sensitivity allows clinicians to detect subtle changes in albumin excretion, enabling early identification of renal impairment and improved management of at-risk patients. By providing accurate and consistent results, the assay supports effective monitoring of disease progression and evaluation of therapeutic interventions in patients with diabetes, hypertension, and other renal risk factors.
This assay is indispensable for hospital laboratories, diabetic care clinics, nephrology units, and research institutions focused on renal and cardiovascular health. Its ready-to-use formulation simplifies laboratory workflows and reduces the risk of pre-analytical variability, while compatibility with automated systems ensures efficiency in high-throughput environments. In addition, it supports clinical research into kidney disease, cardiovascular risk, and metabolic disorders, providing valuable data for understanding disease mechanisms and improving patient outcomes.
The Biorex Microalbumin Assay combines clinical relevance, analytical accuracy, and operational efficiency, making it an essential tool for early detection and ongoing monitoring of renal dysfunction and associated health risks.
Contact Us for more information.